INTRODUCTION
In the fraction of a moment that represents the passing of 20 years since I undertook a review of Yersinia enterocolitica (30) , the microorganism has been the subject of innumerable publications which have simultaneously expanded the knowledge of its basic biology, epidemiology, and clinical correlates while elucidating concepts of virulence through molecular biology technology. The earlier review concluded that "Yersinia enterocolitica remains poised on the threshold of the microbiologic horizon simultaneously inviting and yet defying total elucidation." Time has neither diminished the allure of this "charismatic" microbial species nor tended its innermost secrets. At best, this review will endeavor to cull the efforts of superb global investigators to place before us evolving correlates of a truly versatile microbial species.
HISTORY
The first recognized reference to Y. enterocolitica, a gramnegative coccobacillus, was made in the United States in 1934 by McIver and Pike (152) . These authors described, under the name Flavobacterium pseudomallei Withmore, a small gramnegative coccobacillus that they isolated from two facial abscesses of a 53-year-old farm dweller who also had involvement of the cervical lymph nodes. As the infection was characterized by sinus tract formation, the authors suspected actinomycosis, glanders, or tuberculosis. Ultimately, the infection responded to X-ray therapy. Biochemically, because the isolate did not conform to the glanders agent (Pseudomonas mallei) or even P. pseudomallei, the authors concluded that "the possibility that we are dealing with a new species is perhaps less likely than that the organism here described is an atypical form or variant of some well-known species."
In 1939, Schleifstein and Coleman (199) , working at the New York State Department of Health, called attention to the isolate described by McIver and Pike (which they had received in 1934) and to four others they described as resembling Actinobacillus lignieri and especially Y. (Pasteurella) pseudotuberculosis. Because, however, the microbiologic properties of the five isolates were sufficiently different from those of the last two species and because three of the four isolates were from enteric contents, Schleifstein and Coleman proposed the name Bacterium enterocoliticum for this "unidentified microorganism" (199) . Little did these early New York State investigators realize the foundation they had established as a backdrop for the 1976 outbreak of Y. enterocolitica gastrointestinal infection that struck the hamlet of Holland Patent, N.Y. In my estimation, this singular occurrence propelled unheralded interest in Y. enterocolitica in the United States which, up to this outbreak, was being spearheaded by European investigators (see reference 30 for an extensive review).
TAXONOMY
The differentiation of present Y. enterocolitica from "Y. enterocolitica-like" isolates, which have been described since VanLoghem first established the genus Yersinia in 1944 (in honor of A. J. Yersin, who first described the plague bacillus), has been excruciatingly, if not devotedly, achieved through classic and molecular biology techniques. Setting the taxonomic stage was Frederiksen in 1964 (83) , who enjoined the Schleifstein and Coleman "enterocoliticum" with Yersinia and introduced Y. enterocolitica within the family Enterobacteriaceae. Leading the taxonomic assault through a morass of species ascription were Brenner et al. (41) , who in 1976 applied classic biochemical and DNA-DNA relatedness studies to elucidate four DNA relatedness groups among true Y. enteroco-litica and the "Y. enterocolitica-like" isolates of major concern to the Subcommittee on the Taxonomy of Yersinia, Pasteurella, and Francisella (131) . As a consequence of these studies, Brenner colleagues (17, 42, 238) (Table 1) . Critical to the studies of Brenner et al. (41) and of Moore and Brubaker (160) was the recognition that both indole-negative and indole-positive strains of Y. enterocolitica were sufficiently closely related (DNA hybridization relatedness of 79 to 100%) to be considered Y. enterocolitica rather than the different species Y. enteritidis (indole negative) and Y. enterocolitica (indole positive).
Within Y. enterocolitica sensu strictu, there exists sufficient biochemical heterogeneity to have initially warranted the establishment of five biogroups (249) , which were subsequently expanded to eight ( Table 2) . Wauters et al. in 1988 (252) , however, ascribed the species designations Y. mollaretii and Y. bercovieri to isolates comprising biogroups 3A and 3B, respectively, which differed biochemically and antigenically from well-characterized Y. enterocolitica biogroups. Completing the species designations for Y. enterocolitica-like isolates are Y. aldovae, proposed by Bercovier et al. (18) , who recovered isolates from water sources, and Y. rohdei, isolated from human and canine feces and surface waters by Aleksic et al. (6) . "Y." ruckeri is of uncertain status. Although not the subjects of this review, two premier species, Y. pestis, the plague bacillus, and the closely related Y. pseudotuberculosis, complete the named species within the genus Yersinia of the family Enterobacteriaceae.
ECOLOGY AND HOST RANGE
Y. enterocolitica is widely distributed in nature in aquatic and animal reservoirs, with swine serving as a major reservoir for human pathogenic strains. Interestingly, the majority of nonporcine Y. enterocolitica isolates are of the nonpathogenic biogroup 1A and lack the virulence determinants of invasive isolates. Furthermore, as shown in Table 3 , there is a close association of pathogenic species with a particular animal reservoir.
PATHOGENESIS
Human clinical infections with Y. enterocolitica ensue after ingestion of the microorganisms in contaminated food (23) or water (128) or by direct inoculation through blood transfusion (217) . In the gastrointestinal tract, Y. enterocolitica can cause acute enteritis (especially in children), enterocolitis, mesenteric lymphadenitis, and terminal ileitis. For virulent Y. enterocolitica to manifest its presence through a clinical syndrome, however, it must assemble an array of attributes that enable it to successfully transcend its environmental nidus to infect a human host.
Initially, it is to be appreciated that as the usual route of acquisition of Y. enterocolitica is through contaminated foods, this microorganism must first adapt its surface antigens to accommodate an increase (to 37ЊC) in temperature. This is achieved in part through the presence of a 64-to 75-kb plasmid that is absent in avirulent strains (91, 178, 179) . In the presence of this plasmid, several outer membrane proteins (polypeptides) are expressed at 37ЊC but not at 25ЊC.
The presence of the 64-to 75-kb plasmid, designated pYV by Portnoy and Falkow (179) , codes for an array of proteins which, in a virtual stepwise fashion, guides the invading yersinial patho- Biotype 5 strains may vary in some reactions. See Table 2 .
gen past numerous host defense mechanism to establish itself within its ecologic niche extracellularly or within macrophages. Thus, in conjunction with chromosomally encoded invasion genes (inv, ail), ingested virulent Y. enterocolitica cells possess or synthesize (perhaps in response to host factors, including temperature) traits enabling their invasion of and establishment within the susceptible host. Sequentially, these will be presented as the bacterium orchestrates its formidable armamentarium in response to its immediate environment. Colonization of the intestinal tract is the primary event of the successful enteric pathogen. To achieve this state, the microbe must traverse the intestinal lumen, attach to and penetrate the mucus layer overlying mucosal epithelial cells, and ultimately adhere to intestinal cell brush border membranes.
Studies conducted by Mantle and coworkers (146, 147) have shown that virulent (plasmid-containing) Y. enterocolitica can adhere to purified rabbit and human intestinal mucin to a greater degree than its isogenic, plasmid-cured derivative can. Although surface hydrophobicity is also a plasmid-encoded property in Y. enterocolitica (135) , Mantle and Husar (147) have shown that the binding of Y. enterocolitica to mucin does not involve hydrophobic interactions because suspending Y. enterocolitica in tetramethyl urea, a known inhibitor of hydrophobic interactions, did not reduce mucin binding. Although it appears that a carbohydrate moiety accounts for mucin binding by Y. enterocolitica, the exact mechanism through which mucin adherence occurs is still unknown.
Having traversed the mucus barrier overlying intestinal brush border membranes, virulent yersiniae localize to the distal small intestine (terminal ileum) and proximal colon, where the majority of their pathologic effects and hence clinical manifestation (pseudoappendicitis) occurs. To achieve such localization, virulent plasmid-containing Y. enterocolitica cells synthesize a large outer membrane protein (YadA), which is fibrillar, covers the bacterial surface, and mediates binding to HEp-2 cells (109) and intestinal brush border membranes (146, 166) , especially in the ileocecal region of the gut. YadA, which also accounts for surface hydrophobicity (135) and autoagglutination (210) , is produced at 37ЊC but not at 25ЊC, thus aiding the transition from the environment to the host. Furthermore, the dynamics of bacterium-mucus interaction is also facilitated by the YadA surface component, which promotes bacterial adherence to mucus. Paerregaard et al. (166) have nicely shown that mucus-entrapped yersiniae multiply at a high rate in this matrix by metabolizing either mucin itself or some other constituent of mucus. Additionally, mucus coating of yersinial cells alters its surface from hydrophobic to hydrophilic, which may enhance its binding to brush border membranes. On the other hand, while it may be argued that "sticking" to mucin is a host defense mechanism against mucus penetration and colonization, for yersiniae mucus entrapment could allow the synthesis of other plasmid-encoded, temperature-related virulence traits necessary for invasion (e.g., bacteremia) as a function of host status (e.g., immunosuppression, iron overload) at the time of bacterial entry. Ingested virulent Y. enterocolitica cells, perhaps aided by plasmid-encoded YadA, journey to their preferential site of attachment, M cells overlying Peyer's patches. To continue to escape host defenses operative in the bowel, Y. enterocolitica cells, like other enteroinvasive bacterial species such as Salmonella and Shigella spp., penetrate M cells (specialized cells in the follicle-associated epithelium of Peyer's patches involved in antigen uptake) to gain access to and multiply in subjacent tissue. Invasion is multifactorial requiring chromosomally encoded gene products coupled to the natural phagocytic activity of M cells.
Prior to the molecular elucidation of cellular penetration by Y. enterocolitica, it was recognized that pathogenic serogroups (strains) of Y. enterocolitica invaded HeLa cells (141, 195) . Subsequent elegantly conceived and executed molecular analyses conducted by Isberg and Falkow (119) of cellular penetration by Y. pseudotuberculosis led to the cloning of a chromosomal locus termed inv. The inv locus was found to be necessary for invasion of HEp-2 cells by this bacterium, and its transfer to a noninvasive Escherichia coli K-12 strain confers cell culture invasiveness on this innocuous strain (119) . The inv gene encodes a 987-amino-acid (103-kDa) outer membrane protein, which directly initiates cell penetration by attaching to Lipase activity (155) showed that inv was also present in Y. enterocolitica and that another chromosomal gene locus, named ail (for attachment invasion locus), encodes a factor that also promotes the invasion of epithelial cells (155) . Thus, in addition to the plasmid-encoded YadA attachment factor, Y. enterocolitica adherence to cultured mammalian cells is a function of two chromosomally encoded gene products ("entry proteins") that confer tissue specificity with regard to cultured mammalian cells (119) . Furthermore, environmentally derived Y. enterocolitica strains lacking chromosomal sequences homologous to the ail gene are avirulent and are not associated with human disease (156) .
To this juncture, we have seen that virulent strains (serogroups) of Y. enterocolitica possess both plasmid-mediated and chromosomally encoded outer membrane proteins necessary for adherence to and invasion of cell cultures. On the other hand, avirulent isolates of Y. enterocolitica from human or environmental sources do not contain functional inv homologous sequences and lack the ail locus (173) . Before the discovery of pYV, however, Lee et al. (141) showed that isolates of Y. enterocolitica from human infections invaded HeLa cells whereas nonpathogenic strains of biogroup 1A (esculin positive) lacked this property. Subsequently, Scheimann and Devenish (195) showed that tissue invasiveness was not dependent on the presence of pYV, an observation confirmed in due time by Lian et al. (144) . These latter authors did, however, postulate a significant role for the virulence plasmid in the proliferation of Y. enterocolitica within mucosal tissues (not epithelial cells [74, 212] ) to establish infection in the lamina propria and Peyer's patches.
Using an intradermal rabbit model, Lian et al. (144) further showed that plasmid-encoded cell surface components of Y. enterocolitica act as antiphagocytic factors and that resistance to phagocytosis was eliminated by pronase treatment of whole cells, which removed the plasmid-encoded outer membrane proteins. Additionally, a plasmid-negative strain was readily phagocytized by polymorphonuclear leukocytes and mononuclear cells. While both plasmid-negative and positive strains are capable of invasion of colonic mucosa, only the plasmidbearing strains synthesize outer membrane components at 37ЊC, are resistant to phagocytosis, and are able to multiply in the lamina propria. Preliminary studies by Lian et al. (143) have shown that once adapted to a 37ЊC environment, plasmidencoded surface structures are fully expressed in the small intestines of rabbits as early as 6 h after oral administration of virulent Y. enterocolitica.
As noted above, human pathogenic Yersinia species (Y. enterocolitica, Y. pestis, and Y. pseudotuberculosis) synthesize and secrete several outer membrane proteins (Yops) which play a major role in yersinial virulence (68, 221) . Genes encoding yersinial Yops are located on a 70-to 75-kb plasmid and are temperature and calcium regulated, being expressed maximally at 37ЊC in response to the presence or absence of millimolar concentrations of calcium (220, 222) . In the absence of Ca 2ϩ at 37ЊC, a set of plasmid-borne operons is induced (low calcium response) which is down regulated at 37ЊC when Ca 2ϩ is present (222) . A number of these Yops enable pathogenic yersiniae to resist phagocytosis (81) ( Table 4) .
Among the critical plasmid-encoded virulence determinants is a secreted protein tyrosine phosphatase (YopH), which acts to dephosphorylate eucaryotic proteins, especially in phagocytic cells (24, 89) . Dephosphorylation interferes with the signal transduction pathways of the target cell(s), especially macrophage-like cells and other immune cells (24) , and thereby hinders phagocytosis. Specifically, Bliska et al. (24) showed that two tyrosine-phosphorylated proteins of 120 and 55 kDa are the primary J774A.1 macrophage targets of the YopH. Thus, by dephosphorylating proteins in the signal transduction pathway, the signal to a cellular response is aborted. This activity, which is referable to a phagocytic cell, could impede phagocytic activity directly or indirectly by inhibiting signals (chemoattractants) that would call forth phagocytic cells to an invaded focus.
The ability of Y. enterocolitica to evade an ensuing immune defense after ingestion is centered about an outer membrane protein, YopB, which suppresses the production of a macrophage-derived cytokine, tumor necrosis factor alpha (TNF-␣), known to play a central role in the regulation of cellular immunity and inflammatory responses to infection (20) . Using Y. enterocolitica serogroup O:8, Beuscher et al. (20) showed that release of plasmid-encoded YopB caused a dramatic decrease in the steady state level of TNF-␣ mRNA. These authors speculated that since YopB has sequence similarity to contact hemolysins, such as IpaB of Shigella species, pore formation on the macrophage membrane could alter a signal transduction for TNF-␣ gene expression or affect TNF-␣ mRNA translation. The exact molecular target on the macrophage membrane for YopB is presently unknown.
Prior to dissecting the actual histology of gastrointestinal infection by Y. enterocolitica, one must recapitulate the definitive role of temperature as it bears on the expression of plasmid-encoded and chromosomally transcribed determinants of virulence (Table 4) . Among the latter affected by growth at elevated (35 to 37ЊC) temperatures are changes in the sugar and fatty acid composition of Y. enterocolitica lipopolysaccharide (150) . Cells grown at 25ЊC have a "smooth" lipopolysaccharide and express complete O-antigen side chains, whereas cells grown at 37ЊC are rough and lack bacteriophage X1 surface receptors (127) .
Concordant with thermally regulated chromosomal features are the virulence determinants encoded by the 40-to 50-MDa plasmid. Among those expressed at 37ЊC are Ca 2ϩ dependence for growth (91) , serum resistance of some isolates (59, 170) , and morphologic changes correlated with the presence or absence of four major outer membrane proteins (181), e.g., a bacillary morphology at 37ЊC and coccobacillary morphology at 25ЊC (30) . After the initiation of infection, the pYV virulence plasmid plays a major role in Yersinia-host cell interactions, among which resistance to serum bactericidal activity is paramount for extracellular growth and systemic spread. Resistance to complement-mediated killing by Y. enterocolitica is manifested at 37ЊC and has been correlated with the presence of two outer membrane proteins, YadA (11, 148) and Ail (148, 174, 244 It is stressed that there may well exist a thermal gradient over which the virulence plasmid expresses its determinants. While 37 to 35ЊC is needed for full expression of outer membrane proteins affecting virulence, cells grown at 25ЊC may have low copy numbers of these proteins or, as postulated by Portnoy and Martinez (180) , the virulence plasmid-encoded outer membrane proteins may be present in the cytoplasmic compartment of Y. enterocolitica grown at 25ЊC but not transported to the external membrane until an environmental shift to 37ЊC is perceived. These data reaffirm that Y. enterocolitica undergoes a "hot-cold" cycle of transmission (30) in which the organisms may exit a warm host containing its armamentarium of temperature-inducible characteristics, contaminate an environmental source such as food or water, down regulate (not abolish) the synthesis of these attributes, and increase protein copy numbers upon reexposure to 37ЊC.
Support for this concept may be inferred by noting that Y. enterocolitica organisms grown at 25ЊC are more efficient at adhering to and invading cultured mammalian cells than are those grown at 37ЊC (141) . This phenomenon coincides with the thermoregulation of invasin synthesis, which is expressed maximally after growth at 28ЊC. With adaptation to a 37ЊC host temperature, the second adherence and invasion factor ail is produced and highly expressed on the surface of Y. enterocolitica. Concomitant with adaptation to 37ЊC, plasmid-encoded virulence factors, such as resistance to phagocytosis by polymorphonuclear leukocytes (143) , intracellular killing by macrophages (236) , and resistance to the bactericidal effect of human serum (59, 170) , all favor in vivo establishment.
It appears as if there is an exquisitely tuned, temperatureregulated, inverse relationship among virulence traits of Y. enterocolitica. Initially, after oral ingestion, usually from a cold food source, e.g., chocolate milk (23) or water (128), virulent Y. enterocolitica organisms use chromosomally mediated determinants expressed at low temperatures to establish colonization, and, as acclimation to mammalian host temperatures ensues, plasmid-encoded determinants are gradually expressed to offset early host defense mechanisms, e.g., phagocytosis and intracellular killing. It may therefore be envisioned that in this thermally responsive adaptation process, many Y. enterocolitica cells in the initial inoculum are removed by host defenses and what governs the clinical outcome (enteritis, systemic spread) is determined not only by the serogroup of the ingested strain but also by the rapidity with which surviving yersinial cells may express host-refractory determinants. Such a balance between the thermoregulation of virulence determinants by individual ingested cells may also affect the incubation period between the ingestion of virulent yersiniae and clinical manifestation(s), if any.
Y. enterocolitica invokes a wide array of gastrointestinal syndromes such as enteritis, enterocolitis, acute mesenteric lymphadenitis, and terminal ileitis, which are determined in part by the age of the host, serogroup of the invading Y. enterocolitica strain, and underlying host condition. However, despite the recognition of these syndromes in human hosts and of the numerous observations of Y. enterocolitica showing adherence and invasiveness in cultured mammalian cells in vitro, it remains unanswered whether this species is transported across epithelial borders into the lamina propria by M cells, as has been demonstrated for other enteroinvasive (Shigella, Salmonella, and Campylobacter) genera (100, 133, 245, 247) .
Y. enterocolitica and Y. pseudotuberculosis penetration of M cells is mediated by three invasion genes (inv, ail, and yadA); two of these, inv and ail, are chromosomally located, and the third, yadA is found on the virulence plasmid (25, 119, 155, 258) . The inv gene encodes an outer membrane protein, invasin, which initiates cellular entry by binding to integrin receptors on epithelial cells (120, 155, 172) , while yadA confers low-level Y. enterocolitica invasion by encoding an outer membrane protein (YadA) which promotes adhesion to cultured epithelial cells (109, 244) . The role of yadA in invasion was determined by the use of Y. enterocolitica (244) and Y. pseudotuberculosis (258) inv mutants, which showed residual internalization in the presence of the Yersinia virulence plasmid containing only yadA sequences (258) . Furthermore, mutations in the yadA gene alone, or together with inv, eliminated uptake (258) .
Early histologic studies by Carter (56), Une (236) , and Robins-Browne et al. (190) , using a variety of animal models, established that the initial site of infection after oral challenge with Y. enterocolitica serogroup O:8 (56) or O:3 (190) occurs in Peyer's patches of the distal cecum, resulting in microabscesses which enlarge to obliterate the Peyer's patches, ulceration of the overlying epithelium, and an inflammatory reaction. Infection subsequently spreads to the mesenteric lymph nodes and may cause large abscesses in the medullary region (56) .
While these early studies made use of examination of histologic sections by light microscopy, Hanski et al. (105), using immunohistochemistry and electron microscopy, confirmed that oral ingestion of Y. enterocolitica serogroup O:8 does involve Peyer's patches as the main route of infection. In fact, these investigators showed that Peyer's patches were about 1,000 times more heavily colonized than was the surrounding epithelium of a comparable surface area, a characteristic attributed to a putative facilitated passage through the dome (M-cell) epithelium. As noted above, colonies of Y. enterocolitica could be observed beneath but not within the intact epithelium of Peyer's patches. At 3 days postinfection, the whole Peyer's patch was colonized and its normal architecture was destroyed. Interestingly, the initial basement membrane of M cells overlying Peyer's patches exhibited gaps (Ͼ10 mm) through which the bacteria could freely pass into the lamina propria.
Continuing the elegant studies of Hanski et al. (105), Grütz-kau et al. (101) , in the same laboratory, confirmed their earlier studies that plasmid-bearing and non-plasmid-bearing Y. enterocolitica serogroup O:8 strains are transported from the host lumen into the lamina propria by M cells. Through the use of scanning electron microscopy, these investigators assembled a constellation of montages that showed the transport of Y. enterocolitica through M cells and the resistance of plasmidbearing strains to phagocytosis by professional phagocytes (neutrophils and macrophages). Continued proliferation of bacteria in the lamina propria enabled bacterial survival and spread to other organs, e.g., liver, spleen, and mesenteric lymph nodes, which is consistent with the histologic manifestations of infection. Nonpathogenic yersiniae also cross the intestinal tract via M cells but are eliminated without disturbing the histologic structure of Peyer's patches.
CLINICAL DISEASE Gastroenteritis
Historically, Y. enterocolitica is primarily a gastrointestinal tract pathogen with, under defined host conditions, a strong propensity for extraintestinal spread. When it infects the gastrointestinal tract, acute enteritis with fever and inflammatory, occasionally bloody, watery diarrhea is the most frequent occurrence, particularly in children. In young adults, acute terminal ileitis and mesenteric lymphadenitis mimicking appendicitis appear to be a more common clinical syndrome (23, 58) ( Table 5 ). In more protracted cases of yersinia gastrointestinal tract involvement, fatal necrotizing enterocolitis may occur, as well as a "pseudo-tumorgenic" form of suppurative mesenteric adenitis, even in infants (12, 40) . The yersinial nuance in the extent of gastrointestinal tract pathologic findings centers largely about the serogroup of the invading strain, with serogroup O:8 producing the more catastrophic events, including extensive ulceration of the gastrointestinal tract and death (39, 103) , whereas serogroups O:3 (140, 241) and O:9 are less destructive in the gastrointestinal tract.
The clinical course of gastroenteritis in infants and children is accompanied by fever, vomiting, and diarrhea with bloodstreaked stools (140) . Illness in infants may last for 3 to 28 days (140), whereas adults generally present with a 1-to 2-week history of fever, diarrhea, and abdominal pain usually localized to the right lower quadrant (102, 241) . While the incidence is unknown, infants with Y. enterocolitica enteritis may show a concomitant bacteremia (36, 206) .
Although Y. enterocolitica is known to produce a heat-stable chromosomally encoded enterotoxin, known as Yst (168) , its role in diarrheal disease remains controversial largely because it is maximally produced below 30ЊC in late-log-phase broth cultures (38) . Additionally, although virulent Y. enterocolitica strains are enterotoxigenic (73) , the presence of Y. enterocolitica in a diarrheal stool in experimental animal models is not accompanied by detectable levels of enterotoxin (192) and nontoxigenic serogroup O:3 Y. enterocolitica is capable of producing diarrhea in mice (197) .
Despite contradictory reports, DeLor and Cornelis (72) postulate a role for Yst in the pathogenesis of Y. enterocolitica diarrhea. Using a young-rabbit model, these investigators showed that orogastric inoculation of 1.6 ϫ 10 10 CFU of a serogroup O:9 Yst ϩ Y. enterocolitica resulted in diarrhea and death in 10 of 14 rabbits inoculated. In this group, the inoculated strain was secreted for the duration (7 days) of the diarrheal syndrome and could be recovered in large numbers (10 2 to 10 3 CFU) from the spleens of six animals that died 8 days postinoculation. By way of contrast, of 19 rabbits inoculated with an isogenic Yst Ϫ O:9 strain, 4 developed diarrhea; 2 of the 4 died, but neither the diarrheic stools nor the spleens of these animals contained Y. enterocolitica. Based upon their data, DeLor and Cornelis (72) concluded that in the young-rabbit model at least, Yst played a major role in the Y. enterocoliticainduced diarrhea and promoted in vivo persistence of Y. enterocolitica as evidenced by protracted shedding in feces and spread to the spleens of infected animals. Because the youngrabbit model has many similarities to the human infant, these authors further inferred that Yst could also be involved in acute enterocolitis in the young child. II is antigenically related to Yst and was recognized by monoclonal and polyclonal antibodies raised against Yst. As Yst II was the only potential virulence factor associated with this biotype 1A strain, the authors thought that it could have accounted for the diarrheal illness in the child from whom it was recovered.
Septicemia
Septicemia caused by Y. enterocolitica traverses the spectrum of host health status and may occur in normal (37, 80, 128) and immunocompromised (142, 159, 177) hosts, as well as in those with an underlying disorder (37, 48, 80, 159) . The clinical course of Y. enterocolitica septicemia may include abscess formation in the liver and spleen (184) , pneumonia (21, 177, 213) , septic arthritis (111, 216, 228) , meningitis and panophthalmitis (214) , cellulitis (3), empyema (63) , and osteomyelitis (203) and may evolve into endocarditis (7, 237) or localize in the endovasculature of major blood vessels, leading to a mycotic aneurysm (176) . Acquisition of the infecting strain may be via the oral route or associated with blood transfusion (217) .
In the course of bacteremia or enteritis, pharyngitis with or without cervical adenopathy has also been reported (194, 225) . Rose et al. (194) documented a patient who developed an extensive exudative pharyngitis with massive cervical lymphadenopathy mimicking streptococcal infection. Y. enterocolitica was isolated from the patient's throat, blood, and stools.
Perhaps one of the most intriguing correlates underscoring septicemia with Y. enterocolitica is the almost exclusive association with patients in iron overload or those being treated with the iron-chelating agent desferrioxamine (52, 61, 87, 118, 186, 188, 189, 248) . While it is well recognized that iron is an indispensable growth factor for all life forms, including bacteria (79), this nutritional need as an antecedent to Y. enterocolitica (and Y. pseudotuberculosis) sepsis in the patient with iron overload is exquisitely honed.
To establish an infection, pathogenic bacteria must obtain iron from mammalian tissues. In this setting, however, host iron is tightly complexed to carrier proteins such as serum transferrin or lactoferrin in tissue secretions. Under conditions of low iron availability, most bacteria produce and secrete siderophores which are high-affinity iron chelators. These compounds bind exogenous iron and transport it to the interior of the bacterial cell through specific outer membrane protein surface receptors (79) .
Siderophore production by Y. enterocolitica may be regarded as a virulence factor and has been detected in mouse-lethal strains of serogroups O:8, O:13, O:20, and O:40 but not in mouse-avirulent serogroups O:3, O:5,27, and O:9 (57, 108) . Concomitant with chromosomally encoded siderophore production, the virulence of Y. enterocolitica of both groups is also associated with an iron-repressible outer membrane polypeptide termed FoxA (14, 15) , which functions as a receptor for transporting chelated iron to the interior of the bacterial cell (53, 110) . Yersinial siderophore production is iron regulated and stimulates yersinial growth under conditions of low iron (57) . In part, the innate virulence of serogroup O:8 Y. enterocolitica over other, more commonly occurring serogroups, e.g., O:3 and O:9, resides in its ability to produce and secrete its own catechol-type siderophore termed yersiniabactin (110) (482 Da) or yersiniophore (57) rather than rely on an exogenous source of an iron chelator such as desferrioxamine. Furthermore, although the generally nonpathogenic species Y. intermedia, Y. kristensenii, and Y. frederiksenii do produce a hydroxamate siderophore, aerobactin (223), they are avirulent for mice, indicating that this particular siderophore does not contribute to virulence even when these species are transfected with the virulence plasmid of Y. enterocolitica (108) .
Under conditions of iron starvation, Y. enterocolitica is induced to synthesize several polypeptides, two of which are highmolecular-weight polypeptides (HMWP) of 240,000 (HMWP1) and 190,000 (HMWP2) (54, 55) . These proteins are not thermoregulated, being synthesized at both 25 and 37ЊC only by highly mouse virulent serogroup O:8 strains. The chromosomal gene encoding HMWP2 has been designated irp2 (iron-regulated protein 2) and is absent from the weakly pathogenic serogroups O:3, O:5,27, and O:9 and from avirulent environmental isolates (71) . Although the weakly pathogenic serogroups harbor the virulence plasmid, infection with these serogroups of Y. enterocolitica in the absence of the irp2 gene is restricted mainly to the gastrointestinal tract. However, in the presence of an excess of iron, as may be encountered in ironoverloaded patients, systemic infection may ensue.
The exact role of the HMWPs has not been determined, although HMWP2 is thought to play a role in the nonribosomal synthesis of small biologically active molecules (102 (14, 132) . While a 78-kDa protein was determined to be a hemin receptor (HemR) (219), hemin uptake from hemecontaining compounds by Y. enterocolitica requires the heminspecific outer membrane receptor which operates similarly to other siderophore iron-scavenging transport systems in gramnegative species. Iron internalization is a TonB energy-dependent translocation process of the siderophore-loaded complex in the outer membrane and the TonB-ExbBD protein in the cytoplasmic membrane (132a) .
Siderophores of Y. enterocolitica function analogously to those produced by many other gram-negative species. They bind to a specific outer membrane receptor and are transported to the interior part of the cell in an energy-dependent TonB transport system (219). Therefore, yersinae are able to use siderophores produced by other organisms such as E. coli to obtain iron (13) .
In the setting of iron overload or of an exogenous siderophore, intrinsically low-virulence Y. enterocolitica serogroups O:3 and O:9, the most common causes of yersinial infections worldwide, may achieve virulence equal to that of serogroup O:8. In fact, Robins-Browne and Prpic (189) infection by enhancing organism growth through the provision of iron and by immunomodulation of human lymphocyte function (9) . Regardless of the exact mode of action, the correlation between iron overload and the use of desferrioxamine as a chelating therapeutic in patients suffering from iron overload and Y. enterocolitica sepsis is well established (27, 57, 153, 157, 159) . Among the risk factors contributing to iron overload are underlying hematologic dyscrasias such as thalassemia (111, 193, 204) , aplastic anemia (111), sickle cell disease (218) , and defects in iron metabolism. Furthermore, Cantinieaux et al. (51) have shown an impairment of neutrophil phagocytic and killing activity against Y. enterocolitica in patients with iron overload. Paradoxically, iron overload and its therapeutic control through desferrioxamine treatment may actually be additive in the provision of growth-promoting iron for siderophorebearing serogroup O:8 strains and desferroxiamine for nonsiderophore-containing serogroup O:3 and O:9, strains and may concomitantly induce aberrations in neutrophil phagocytic killing activity and in immune system function. Bacterial contamination of blood for transfusion is uncommon, but when such an event occurs, morbidity and mortality per individual may be significant (162) . Among the bacterial species, Y. enterocolitica has emerged as a significant cause of transfusion-associated bacteremia and mortality (64%), with 27 cases reported since this condition was first documented in 1975 (44) . A review of these cases (Table 6 ) reveals several common themes reflective of the proclivity of the bacterium to survive low temperatures, its ability to utilize liberated iron from aging erythrocytes, and the suggestion that a transient, even occult bacteremia, may occur in a subpopulation of individuals with Y. enterocolitica gastrointestinal infection. Furthermore, Y. enterocolitica may persist in human tissues and cells from which they may enter donated blood long after a primary intestinal involvement (116) .
The use of cold enhancement at 4ЊC for the growth and recovery of Y. enterocolitica from human clinical specimens is well documented (78, 97, 169, 254) , and Highsmith et al. (113) have shown that environmental (biotype 1A) strains isolated from well water are capable of growth in sterile distilled water at 37ЊC in which their doubling time was 8.4 h. Stenhouse and Milner (217) further demonstrated that when Y. enterocolitica (80 CFU/ml) was inoculated into a fresh unit of whole blood, it achieved counts of 5 ϫ 10 6 after 21 days of incubation at 4ЊC. These authors showed that after an initial 4-day lag phase accompanied by a slight drop to 35 CFU/ml, growth proceeded briskly throughout the duration of incubation. These results suggest, and are borne out by a review of transfusion-associated cases, that as erythrocytes begin to age, they lyse and liberate iron stores, which enhance Y. enterocolitica growth. Amazingly, in 27 reported cases to date, only non-siderophoreproducing serogroups (O:3, O:9, O:5,27, O:123, and O:20) have been recovered from transfused and recipient blood (Table 6).
In the course of their studies, Stenhouse and Milner (217) pondered the rationale underscoring the persistence of Y. enterocolitica in fresh blood containing "complement, opsonic activity, and polymorphonuclear leukocytes." To elucidate these factors, Gibb et al. (92) extended the experiment of Stenhouse and Milner and also showed the lag phase (10 days) followed by logarithmic growth. Using fresh and 14-day-old blood, these authors showed that the initial drop in CFU and the prolonged lag phase could not be attributed to phagocytosis of bacteria by polymorphonuclear leukocytes, which are nonviable after 14 days at 4ЊC. Additionally, when blood units are inoculated with virulence plasmid-containing Y. enterocolitica grown at 37ЊC to express complement resistance, the early drop in CFU is delayed, suggesting that the early loss of Y. enterocolitica cells, as indicated by a drop in CFU, is complement mediated.
However, the recovery and growth of Y. enterocolitica in human blood after the lag phase has not been fully explained (8, 82, 92, 217) . Among the explanations advanced are the entry of Y. enterocolitica into polymorphonuclear or other cells (e.g., platelets), aided by chromosomally encoded invasin (and, to a lesser extent, Ail), a surface protein expressed at lowered growth temperature. Thus, while complement-mediated resistance is lost at 4ЊC in plasmid-bearing strains, penetration into nucleated cells is maintained. Furthermore, in two independent studies (45, 175) of blood units artificially contaminated with Y. enterocolitica O:3, incubation of donated blood at 25ЊC (41) . Inocula of Յ43 CFU/ml were completely removed from artificially contaminated units after a holding period of 7 to 20 h at 25ЊC followed by leukocyte removal (45, 175) .
Several facets of the above studies are worthy of note. Both Buchholz and colleagues (45) and Pietersz et al. (175) showed that after room temperature incubation, the passage of artificially contaminated units of erythrocytes through a leukocyte reduction filter resulted in the removal of small inocula of Y. enterocolitica. These data strongly suggest a role for both complement-and phagocyte-mediated removal of Y. enterocolitica. Support for actual killing of Y. enterocolitica through combined activities may be derived from noting that in both studies cultures of the leukocyte-filtered components were generally negative in blood units challenged with Յ100 CFU of Y. enterocolitica/ml. Unexplained, however, is the persistence of even single Y. enterocolitica clones in the leukocyte-depleted fraction derived from blood units challenged with higher inocula. (59) to be serum resistant at 25ЊC, are not removed by leukocyte filtration, survive 25ЊC holding temperatures, and ultimately multiply during storage at 4ЊC.
It would appear that donated blood containing small numbers of Y. enterocolitica cells should be cleared of most non-O:3 isolates merely by incubation at 25ЊC for 7 to 20 h through the combined effects of serum bactericidal activity, phagocytosis, and leukocyte filtration. The susceptibility of serogroups O:9 and O:5,27 to serum bactericidal activity has also been demonstrated (59) but to a lesser degree than that of serogroup O:8 (59). This observation could account for their survival and recovery from stored human blood; a similar phenomenon may pertain to serogroups O:1,2,3 and O:20.
Another hypothesis accounting for the survival of Y. enterocolitica in donated blood is their sequestration in leukocytes (114). Hogman et al. (114) tested this hypothesis by inoculating Y. enterocolitica serogroup O:3 (100 CFU/ml) into whole blood and buffy coat preparations and then removing leukocytes from some whole-blood units by filtration. They showed the typical lag phase shortly after inoculation, followed, after 4 of weeks incubation at 4ЊC, by massive growth of Y. enterocolitica in the (leukocyte-containing) whole-blood units but not in the leukocyte-reduced units. These investigators concluded that phagocytosis of yersinial cells in whole blood had ensued but internalized cells were released upon leukocyte disintegration, with resultant bacterial multiplication. They therefore recommended leukocyte reduction of whole blood as a means of curtailing transfusion-related yersiniosis. It is to be stressed, however, that total removal of leukocytes from a blood unit may not be achievable (70) .
Several other strategies have been proposed to eliminate transfusion-associated yersiniosis. These include screening donors for a history of gastrointestinal illness within 4 weeks of donation (2, 44, 99, 106) . A study conducted by Grossman et al. (99) showed that 6% of 11,323 donors gave a positive response to a question about a history of gastroenteritis. The authors deemed this percentage to be too high to exclude donors on the basis of a general question which could not differentiate the etiology of the diarrheal illness. Furthermore, not all blood donors with asymptomatic Y. enterocolitica infection give a history of diarrhea prior to donation (158) .
Reducing allowable storage times for packed erythrocytes has also been proposed as a measure to reduce both the microbial burden and endotoxin levels in Y. enterocolitica-contaminated blood. It has clearly been shown that Y. enterocolitica inoculated into a fresh unit of whole blood could achieve counts of 10 6 CFU/ml 21 days postinoculation at 4ЊC (217), and mean endotoxin levels of 240 to 600 ng/ml were detected between 21 days and 6 weeks of storage (8) . Studies conducted by Hastings et al. (106) , however, have shown that even if the storage times were reduced to 14 days, blood contaminated with Y. enterocolitica would contain sufficient endotoxin levels (Ͼ75 ng/ml) to cause severe shock and even death. Perhaps, as suggested by Pietersz et al. (175) , an alternative to reducing storage times is to hold whole blood at 22ЊC for 6 to 24 h, which would allow complement-and leukocyte-mediated removal of yersinial contamination prior to leukocyte removal and refrigeration. This approach is also supported by the data of Kim et al. (130) , who advocate the removal of leukocytes with leukocyte reduction filters as a means of reducing the growth potential of Y. enterocolitica by 80% in contaminated blood units. A cautionary note regarding the filtration of all blood after a holding period was enunciated by Nusbacher (165) , who stated that such a policy should be considered after all risks, costs, and benefits have been carefully weighed. More somberly, Hastings et al. (106) speculated on the future use of molecular biology techniques such as PCR to detect a single bacterial cell in contaminated blood but concluded that "in the meantime, this very rare complication of blood transfusions would appear to be unavoidable."
Sequelae
Secondary immunologically mediated sequelae of acute Y. enterocolitica infection such as arthritis and erythema nodosum, which are the most common, and Reiter's syndrome, glomerulonephritis, and myocarditis have been reported predominantly among Scandinavians and in the setting of Y. enterocolitica serogroup O:3, biotype 4, phage type 8 infections (138) ( Table 7) Based on serologic studies, a connection has been noted between yersinia and thyroid disorders (16, 208) . Antibody titers to serogroup O:3 Y. enterocolitica were detected in up to 52% of patients with thyroid disorders in New York (208) . There are, however, two lines of evidence to suggest that Yersinia-specific antibodies are cross-reactive with thyroid tissue rather than having a causal role in thyroid disorders. Initially, in the United States, when the report of Shenkman and Bottone appeared in 1976 (208) Y. enterocolitica is widespread in nature, occurring in reservoirs ranging from the intestinal tracts of numerous mammals, avian species, and cold-blooded species (134) . Y. enterocolitica has also been recovered from terrestrial and aquatic niches (19) . While most environmental isolates are avirulent (19) , isolates recovered from porcine sources comprise human pathogenic serogroups (e.g., O:3, O:9, and O:5,27) and the highly virulent O:8 serovar (19, 75, 76, 86, 229) . Furthermore, a close correlation has been established between ecologic distribution, serobiovar, and human pathogenic potential (Table  3) .
Because of such a wide and diverse reservoir in nature, food products such as dairy products, meats (e.g., pork and poultry), and vegetables would seem to be at greatest risk for contamination with Y. enterocolitica. However, although individual cases are centered about regions in which pig reservoirs predominate, e.g., in Europe (229), only sporadic outbreaks of food-borne illness have occurred. The close association with ingesting raw or undercooked pork products and Y. enterocolitica infection has been epidemiologically strengthened by the study of Tauxe et al. (229) conducted in Belgium and by two reports in the United States of yersiniosis developing after the handling of raw pig intestines (chitterlings) (129, 218) . Sporadic or outbreak cases of yersiniosis have also occurred in the setting wherein household dogs have also been symptomatic, suggesting that domestic animals may also serve as reservoirs (103) but not necessarily as direct vectors of Y. enterocolitica. Because Y. enterocolitica infections occur most frequently in young children, it is conceivable that an association with domestic animals may serve as a link in transmission. Against this concept is the fact that children with diarrhea are more readily brought to medical facilities, where a stool specimen is cultured for "enteric pathogens." Thus, the vehicle of transmission may be identical for children and adults alike and unrelated to domestic animals.
Food-Borne Outbreaks
Outside the setting of outbreaks of Y. enterocolitica infection involving several individuals or family members, most sporadic infections cannot be traced to a particular vehicle or event. In contrast, in five of six major outbreaks that have occurred in the United States since 1976, a source could be identified (Table 8) .
Two of these outbreaks (23, 207) were milk-borne, and in a third (226) , pasteurized milk was statistically associated with the outbreak. Serogroup O:8 Y. enterocolitica accounted for four of the six episodes, while serogroups O:13a,13b and O:3 and O:1,2,3 accounted for one each (Table 8) . One of the outbreak strains of serogroup O:8 associated with tofu consumption was unusual in being indole negative, a finding substantiated by Toma et al. (234) in their examination and description of the O:13a,13b strain isolated from the putative milk-borne outbreak that occurred in the southern United States (226) . This particular outbreak strain, which agglutinated most strongly with antisera to Y. enterocolitica serogroups O:13 and O:18, as well as eight nonhuman isolates were characterized as forming a new serogroup, O:13a,13b (234) .
The most recent (1989) outbreak of Y. enterocolitica serogroup O:3 infection associated with the household preparation of chitterlings (140) with secondary autoimmune phenomena ( Table 7) . Furthermore, the findings suggest the emergence of phage type 8 in the United States and reveal that two different O:3 strains of Y. enterocolitica were responsible for the outbreak, in addition to one serogroup O:1,2,3. Multiple serogroups (strains) of Y. enterocolitica were also recovered in two other food-borne outbreaks (207, 227) .
Nosocomial Infections
Nosocomially acquired Y. enterocolitica outbreaks of diarrheal disease have also been documented (151, 185, 233) . The first recorded outbreak occurred in Finland (233) and involved six members of a hospital staff on two different wards who had taken care of a schoolgirl treated consecutively on the wards. Y. enterocolitica serogroup O:9 was isolated from the stools of the index patient and hospital personnel. Abdominal pain and diarrhea developed in the patients with secondary cases about 10 days after the index patient was admitted. The route of transmission was suspected to be person-to-person. However, since the tested inocula necessary to produce yersinial gastroenteritis is 10 9 CFU/ml (77), it seems questionable that person-to-person spread had actually occurred. More probable, a common-source contamination had occurred linking the hospitalized patient and the infected hospital personnel.
Ratnam et al. (185) described a nosocomial outbreak of Y. enterocolitica serogroup O:5, biogroup 1 (1A) diarrheal illness which involved nine hospitalized patients. The index patient was asymptomatic upon admission but had a rectal drainage culture performed after a temporary colostomy. Y. enterocolitica serogroup O:5, biogroup 1 (1A) was isolated only after enrichment in selenite broth and culture to MacConkey agar. Taking into account the index patient, six of the nine individuals involved had Y. enterocolitica isolated only after enrichment of their stool specimens for 24 h at 37ЊC while the remaining three patients yielded Y. enterocolitica serogroup O:5, biogroup 1 (1A) both on direct plating and after enrichment of their stool specimens. Cold enrichment of stool specimens for the recovery of Y. enterocolitica has been advocated by several investigators (78, 97, 169, 254) . Van Noyen et al. (239, 240) , however, have clearly shown that cold enrichment is of no value in the diagnosis of acute gastroenteritis caused by serogroups O:3 and O:9, as numerous yersiniae are being shed and hence are recoverable upon direct stool culture. Furthermore, these authors (239, 240) , as well as Weissfeld and Sonnenwirth (254) , have shown that Y. enterocolitica strains, including serogroup O:5, isolated after cold enrichment for up to 21 days are nonpathogenic members of biogroup 1 (1A).
The report of Ratnam et al. (185) raises many questions in search of a clearer resolution of this problem. First, their serogroup O:5 isolates lacked virulence plasmid-associated markers such as autoagglutination (137) . Second, the isolates were recovered from an asymptomatic index patient and from six of the nine patients only after broth enrichment. Third, many of the patients, including a neonate (patient 9), did not have contact with each other. Yet six patients developed diarrhea subsequent to hospital admission of the index patient and one patient (patient 6) was admitted to the hospital with severe gastroenteritis and Y. enterocolitica serogroup O:5, biogroup 1 (1A) was isolated from the stool only after broth enrichment. Taken together, the evidence indicates that a common-source community or hospital outbreak may have taken place rather than person-to-person spread as the authors speculate. This scenario could account for the diarrheal illness that occurred in the 9 patients, all of whom had an underlying disorder or were compromised by age (elderly, neonate), and the absence of illness among 152 asymptomatic healthy hospital staff members surveyed and 42 randomly selected hospitalized patients. Regardless of the mode of transmission, the report of Ratnam et al. (185) does confirm earlier publications that so-called atypical Y. enterocolitica, now known as Y. intermedia and Y. kristensenii, is capable of causing infections in rare instances (31, 32, 191) .
The third instance of hospital-acquired Y. enterocolitica gastroenteritis was reported by McIntyre and Nnochiri (151). The index patient was an 81-year-old diabetic woman who was admitted to a six-bed unit with a 3-day history of diarrhea, intermittent abdominal pain, nausea, and low-grade fever. At 72 h later, a 68-year-old female patient in the opposite bed, admitted 5 weeks previously with hypothermia, developed gastroenteritis. Y. enterocolitica serogroup O:6,30, biogroup 1 (1A) was recovered from the stools of both patients. Stool specimens from four other patients in the same unit as well as 41 staff members were negative for Y. enterocolitica. Although both isolations were achieved on yersinia selective media (CIN agar) (195) , it is unclear if recovery was by direct plating or after selenite broth enrichment. This instance may again reflect the capability of an "innocous" serobiogroup of Y. enterocolitica to produce disease in compromised hosts.
DIAGNOSIS Culture
The microbiologic diagnosis of Y. enterocolitica infections is best achieved by isolation of the bacterium from a clinical specimen representative of the infectious process. However, isolation and biochemical identification are functions of the nuances imposed by incubation temperature and colony characteristics of Y. enterocolitica on a variety of commonly used routine and "enteric" media (28) .
Y. enterocolitica grows well on most enteric media with the -colored) and xyloselysine-deoxycholate (yellow) agars resemble those of the normal enteric flora. Furthermore, after a 24-h incubation at 37ЊC, colonies of Y. enterocolitica are pinpoint and barely perceptible against a background of more rapidly growing colonies of other enteric bacterial species present in fecal samples. Because of the slower growth of Y. enterocolitica at 37ЊC, stool specimens should be plated to a duplicate set of media for incubation at 25ЊC; alternatively, after the 37ЊC incubation, inoculated media can be reincubated at 25ЊC for an additional 24 h and examined for pinpoint colonies suspicious for Y. enterocolitica. While several technical approaches, e.g., scanning agar surfaces under stereoscopic microscopy (249), have been advanced for the recognition of Y. enterocolitica colonies, the use of a selective medium appears to be easiest. Several media have been developed (reviewed in reference 30); of these, two formulations, CIN agar developed by Schiemann in 1979 (196) and virulent Yersinia enterocolitica agar (VYE) formulated by Fukushima in 1987 (85) , seem the most useful. Head et al. (107) conducted comparative studies of several selective media including MacConkey agar for the recovery of Y. enterocolitica. They found that CIN agar was the most effective, yielding 100% recovery of Y. enterocolitica in a test suspension containing 10 CFU/ml. CIN agar dramatically inhibits normal flora organisms while Y. enterocolitica gives rise to distinctive colonies with deep-red centers (196) and a sharp border surrounded by a translucent zone. The red pigmentation is a result of mannitol fermentation. The decision to routinely use a selective medium such as CIN agar should be tempered by the incidence of Y. enterocolitica infections in a given geographical area (124) .
Fukushima and Gomyoda (84) Biochemically, an isolate may be suspected to be Y. enterocolitica (or even Y. pseudotuberculosis) if it displays anaerogenic fermentation of glucose and other carbohydrates, produces urease, is motile at 25 but not 37ЊC, and lacks oxidase, phenylalanine deaminase, lysine decarboxylase, and arginine dihydrolase activities (Table 1) 
Serologic Diagnosis
The serologic diagnosis of Y. enterocolitica infection through assessment of serum agglutinins has limited applicability for individual patients in the United States (34) . In contrast, serologic testing has been used extensively outside of the United States, especially for the diagnosis of serogroup O:3, phage type 8 and serogroup O:9 infections, which account for over 90% of Y. enterocolitica infections in Europe and Japan. Serum antibody responses ranging in titer from 80 to 20, 480 have been recorded within 2 to 7 days of acute infection. A trend toward higher titers during late reactive sequelae has also been noted (5, 255, 256) . Furthermore, elevated titers may persist for years.
In the United States, brisk antibody titers detected by bacterial agglutination are elicited in response to serogroup O:8 infections (23, 34, 103, 128) , but when documented, spurious responses have been obtained in individual cases of infection due to other serogroups (34) . In an outbreak setting, however, such as the multistate outbreak attributed to Y. enterocolitica serogroup O:13a,13b (226) , the median antibody titer was 2,048 among 15 adult patients and 64 among healthy controls. In 15 patients aged 16 years or less, the median antibody titer was 1,024; for 23 controls of similar age, the titer was 8. Under outbreak circumstances, antibody detection may prove valuable, especially among symptomatic patients from whom Y. enterocolitica has not been isolated.
The utility of serologic testing as a diagnostic adjunct for Y. enterocolitica infections is also tempered by the geographic locale and the potential for cross-reactions with other members of the Enterobacteriaceae, e.g., Morganella morganii and Salmonella spp. (65) and cross-reactions between serogroup O:9 Y. enterocolitica and Brucella abortus (65) and between serogroup O:3 and Rickettsia spp. (200) . Additionally, as noted previously (208) , patients with thyroid diseases may show persistent antibody titers (Յ256) to serogroup O:3 Y. enterocolitica in the absence of exposure to Y. enterocolitica.
To circumvent some of the spurious results obtained with agglutination studies, Granfors (93) , by using formalinized or heat-treated cells of serogroups O:3 and O:9, respectively, developed an enzyme-linked immunosorbent assay (ELISA) for the detection of IgM, IgG, and IgA antibodies against Y. enterocolitica. The ELISA compared favorably with the agglutination test but, additionally, allowed for the detection of classspecific antibodies (IgA and IgG) not identified through agglutination studies. Furthermore, a single sample assayed by ELISA for IgM antibodies could prove diagnostic for a recently acquired infection. Of particular value was the persistence (9 to 12 months) of IgA class Yersinia antibodies in patients whose yersiniosis was complicated by arthritis. This was in contrast to an absence of IgA antibodies within 3 months in the sera of patients with uncomplicated cases of yersiniosis. High levels of IgA and IgG antibodies to Yersinia persist longer in the circulation of HLA-B27-positive patients with arthritis than in the circulation of HLA-B27-negative patients with gastrointestinal symptoms only (94) .
Since its introduction, the ELISA has been modified by using Y. enterocolitica serogroup O:3 lipopolysaccharide rather than whole cells as the binding antigen (98) . In comparing whole-bacterium ELISA with lipopolysaccharide, Granfors et al. (95) showed good correlation for each immunoglobulin class. Cross-reactions between Y. enterocolitica serogroup O:9 and B. abortus were still apparent in both assays but could be differentiated by an inhibition ELISA with whole bacteria or lipopolysaccharide for the inhibition.
The serologic diagnosis of Y. enterocolitica infections is still troublesome. While the ELISA technique affords increased sensitivity in assessing antibodies (IgG and IgA) not detected by bacterial agglutination, cross-reactive and false-positive results also occur with the ELISA technique (242). Vesikari et al. (242) studied the use of ELISA in the diagnosis of Y. enterocolitica diarrhea in children. Six sera showed elevated IgM titers, which were considered to be falsely positive because of an absence of a concomitant rise in the level of IgG or IgA antibodies. These authors concluded that a positive diagnosis of acute Y. enterocolitica gastroenteritis should be accompanied by a rise in the level of IgM, IgG, and IgA anti-yersinia antibodies. In contrast to this conclusion, Paerregaard et al. (167) , using whole pYV ϩ O:3 cells as a capture antigen, found that testing for IgA and IgM antibodies did not add any diagnostic utility to tests for IgG antibodies alone for the detection of recent infection.
The above-cited studies regarding the use of the ELISA technique have been conducted largely in Finland, where the background level of anti-Yersinia antibodies is relatively high: 4% in the general population, 9% in patients with inflammatory joint disease, and 19.4% in patients with ankylosing spondylitis, Reiter's disease, or other reactive arthritis (95) . Furthermore, few patients with culture-proven Y. enterocolitica infection were studied. Therefore, in the absence of culturally confirmed cases of Y. enterocolitica infection, it is difficult to assess the significance of a single positive antibody test. Additionally, as pointed out by Lange and Larsson (139) , to fully establish the utility of serologic testing in the diagnosis of Y. enterocolitica infection, only cases of culture-verified infection should be included and the sera should be reacted against serogroup-specific antigens to correlate with the isolated Y. enterocolitica strain. In this regard, these authors concluded that too few such studies have been conducted to permit definitive conclusions on the reliability of serum antibody determination as a diagnostic tool in Yersinia infection.
The diagnosis of Y. enterocolitica infection has also been sought by indirect immunofluorescence (IF) examinations of mesenteric or cervical lymph node, ileocecal biopsy, pus, and colonic resection specimens (115 
Assessment for Virulence Traits
With certain bacterial species recovered from enteric contents, the significance of the isolate is inherent in the species designation. Thus, the laboratory report of a Salmonella, Shigella, Campylobacter, or Vibrio species may connote significance in the setting of a diarrheal illness. With Y. enterocolitica, however, in contrast to Y. pseudotuberculosis, the significance resides mainly in whether the isolate belongs to a pathogenic serogroup or biogroup (Table 3 ). In the absence of antisera to serogroup Y. enterocolitica isolates in routine microbiology laboratories, significance remains a function of assessing an isolate for plasmid-encoded virulence factors. These include autoagglutination, production of V (immunogenic protein) and W (nonprotective lipoprotein) antigens (55), serum resistance, calcium dependency for growth at 37ЊC, Congo red binding, and even plasmid profile (35) . Other virulence assays include lethality for mice, production of conjunctivitis in guinea pig eyes (Sereny test) (205) , and absence of pyrazinamidase activity (125) . Many of these plasmid-related tests are beyond the capability of routine microbiology laboratories. Following the biogroup scheme of Wauters et al. (251) (Table 2) , however, nonpathogenic isolates of Y. enterocolitica can be quickly recognized because they rapidly ferment salicin (35ЊC), hydrolyze esculin (25ЊC), and are pyrazinamidase positive. As slow (Ͼ4 days) utilization of salicin and esculin may occur on prolonged incubation of pathogenic strains, the results of these tests should be read in 24 to 48 h. I believe that it is prudent to temper the significance of isolation of an "avirulent" yersinial isolate from diarrheagenic patients. For instance, Bottone and Robin (31) The dilemma posed by attempting to ascribe clinical significance to a Y. enterocolitica or non-enterocolitica species applies mainly to stool isolates. Perhaps the decision of clinical significance may not be a microbiologic parameter but, rather, one of exclusion. The recovery of a Y. enterocolitica strain or other Yersinia species from the stool of a symptomatic patient by direct cultivation or after minimal (24 to 48 h) cold enrichment and the absence of another potential etiologic agent may imply significance regardless of the virulence attributes. If need be, tests for esculin hydrolysis, salicin fermentation, and pyrazinamidase activity may be performed, recognizing that most (but not all) isolates conforming to recognized virulent Y. enterocolitica serobiogroups will render a negative reaction. For non-Y. enterocolitica isolates, significance may reside in the number of colonies present on direct isolation media, the number of times they were isolated, and epidemiologic parameters such as isolation from other family members or the potential source of the infecting strain; e.g., food or water. Continued studies may show that so-called "avirulent Y. enterocolitica" or non-enterocolitica species may induce gastrointestinal disturbances analogous to those due to enteropathogenic Escherichia coli, e.g., through enteroadherence or some other mechanism(s).
Presence in Foods
Y. enterocolitica, like Listeria monocytogenes, is thought to be a food-borne pathogen, having been recovered from a food source in five of six outbreaks (Table 8) . While it is recognized that Y. enterocolitica is able to multiply in foods kept at refrigeration temperatures, several factors may preclude the more widespread overgrowth of Y. enterocolitica in foods. In pasteurized foods devoid of a resident bacterial flora, Y. enterocolitica may proliferate unimpeded once introduced after pasteurization (23) , perhaps as a function of its tolerance to alkaline conditions (198) . However, in foods with an indigenous bacterial flora, Y. enterocolitica may be inhibited as a consequence of lower pH and the production of antagonistic metabolites (bacteriocins) active against Y. enterocolitica (33, 49, 50 (158) . Because all milk samples tested by Butt et al. (47) were derived from a single source, the sole recovery of Y. intermedia and Y. kristensenii from two milk samples could in fact represent selective isolation of these species over Y. enterocolitica O:6,30 as a consequence of bacteriocin production during incubation in milk. Alternatively, one must then assume the chance contamination of two milk samples with two different Yersinia species.
Could these species have also been present in the nine milk samples yielding Y. enterocolitica O:6,30? Yes, simply because bacteriocin production and action are time dependent and are functions of the original inoculum densities of the producer and susceptible strains at the time of milk contamination. Thus, inoculation of a milk sample to agar media with 37ЊC incubation would result in the indistinguishable colony growth of both species because bacteriocin activity by Y. intermedia and Y. kristensenii is absent at 37ЊC (33, 235) . In most routine bacteriology laboratories, one or two colonies only are selected for advanced biochemical characterization. Therefore, chance could have favored the extensive workup of one clone (Y. enterocolitica) at the expense of another (Y. intermedia, Y. kristensenii) if it was present. Furthermore, the fact that Y. enterocolitica O:6,30 was recovered from milk in the absence of serogroup O:3 raises the question whether the O:3 strain was overlooked by chance for the same technical reasons. Finally, left unanswered is the question whether serogroup O:3 Y. enterocolitica was inhibited by serogroup O:6,30 Y. enterocolitica because of bacteriocin production. Obviously, many questions still need clarification during a search for Y. enterocolitica in food incriminated during an outbreak. Data on whether other bacterial species were present in addition to Y. enterocolitica are usually missing. Furthermore, data on how many colonies are selected for definitive biogroup and serogroup designation should be provided.
Unlike bacteriocin production by Y. intermedia, Y. kristensenii, and Y. frederiksenii, bacteriocin production by "avirulent" Y. enterocolitica strains occurs at both 25 and 37ЊC (49, 235) . This antagonistic substance inhibits isolates of serogroups O:3, O:8, and O:9 whether or not they contain the plasmid (49) . This finding raises the intriguing possibility of feeding such a natural antagonist to known reservoirs of virulent Y. enterocolitica such as pigs. As "avirulent" Y. enterocolitica strains have been recovered from pigs (126, 163, 198) , colonization of the pig intestine by a bacteriocin-producing strain could either prevent or abort colonization by virulent Y. enterocolitica.
Antibiotic Susceptibility
Antibiotic susceptibility patterns of Y. enterocolitica are serogroup specific and are governed in part by the production of two chromosomally mediated ␤-lactamases designated ␤-lactamases A and B (66, 67) . Produced predominantly among serogroup O:3 and O:9 isolates, these ␤-lactamases account for resistance to ampicillin, cephalothin, carbenicillin, and penicillin (66) . Type A ␤-lactamase hydrolyzes a variety of penicillins and cephalosporins, whereas type B ␤-lactamase exhibits strong cephalosporinase activity. Protection against other ␤-lactam antibiotics is exerted synergistically by both enzymes (67) . Thus, a two-enzyme system is operable in Y. enterocolitica serogroups O:3 and O:9 whereas only a type B ␤-lactamase is produced in serogroup O:5,27 (149) . Serogroup O:8, however, unlike the more commonly occurring serogroups, is susceptible to ampicillin but is variably resistant to carbenicillin and cephalothin. ␤-Lactamase activity among serogroup O:8 isolates is distinct from that of serogroups O:3 and O:9. Hence, strains of different serogroups produce different ␤-lactamases, and, with rare exceptions, all strains produce more than one ␤-lactamase. The similar isoelectric focusing patterns of the type A and B ␤-lactamases from Y. enterocolitica serogroups O:1, O:2, O:3, and O:9 and ␤-lactamase type B from serogroup O:5,27 suggests a close taxonomic relationship among these strains. Furthermore, isoelectric focusing of Y. enterocolitica ␤-lactamases tends to group pathogenic strains irrespective of their geographic origin (149) .
Since the early recognition of ␤-lactamase activity among Y. enterocolitica strains, newer ␤-lactam antibiotics such as ceftriaxone, ceftazidime, cefoxitin, moxalactam, and cefamandole, with marked activity against this microorganism, have become available (202, 215) . It is to be cautioned, however, that studies conducted in the early 1980s either reflect data for serogroup O:3 Y. enterocolitica (202) or do not give serogroup designation(s) (215) . More recently, Hornstein et al. (117a) , studying 126 geographically diverse Y. enterocolitica isolates, showed that the earlier data regarding the newer broad-spectrum cephalosporins also applied to 11 serogroup O:8 isolates tested as well as to members of 19 other serogroups, although one strain each was tested from these serogroups. As expected, the pattern of susceptibility of the four major serogroups (O:3, O:5,27, O:8, and O:9) to ampicillin, carbenicillin, cephalothin, cephaloridine, cephalexin, and cefoxitin was distinct for the serogroup. For all serogroups tested, a marked antibacterial activity of imipenem and aztreonam was shown. Clinically, the use of broad-spectrum cephalosporins, often in combination with an aminoglycoside, has resulted in a successful outcome in patients with extraintestinal Y. enterocolitica infection (e.g., septicemia) (90) . Fluoroquinolones alone or in combination have also proven efficacious (90, 117) . Trimethoprim-sulfamethoxazole shows in vitro efficacy (117, 215) but has little effect on the clinical course (duration) of Y. enterocolitica gastroenteritis (171). Cover and Aber (69) recommend treating enterocolitis in compromised hosts. They advise withholding desferoxamine (when indicated) and treating with doxycycline or trimethoprim-sulfamethoxazole for complicated Y. enterocolitica gastrointestinal infection and focal extraintestinal infections.
CONCLUDING COMMENTS
Y. enterocolitica remains a most versatile bacterial pathogen. Endowed with an array of temperature-controlled chromosomal and plasmid-mediated virulence factors, this microorganism has emerged as the prototypical species capable of navigating through various host defense mechanisms to establish itself in the human body. Through arduous and impassioned research, numerous investigators have sought out and elucidated the molecular and biologic nuances underscoring its passage from an environmental reservoir to its adaptation in human hosts. Along the way, correlates of public health concerns have emerged, e.g., acquisition through donor blood and food, which require further study for containment and prevention.
No chapter in the exposition of a bacterial pathogen as evasive as Y. enterocolitica is ever fully written. It will therefore be in retrospect that we may marvel at the ingenuity of dedicated yersiniologists in their research efforts to gain full appreciation of this consummate bacterial pathogen.
